Rocket Pharmaceuticals Inc (RCKT.OQ)
Fri, May 18 2018
* ROCKET PHARMACEUTICALS PRESENTS UPDATED DATA FROM PHASE 1/2 GENE THERAPY TRIAL OF RP-L102 IN PATIENTS WITH FANCONI ANEMIA AT THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) ANNUAL MEETING
* ROCKET PHARMACEUTICALS ANNOUNCES STRATEGIC RESEARCH COLLABORATION
* ROCKET PHARMACEUTICALS APPOINTS GAYATRI R. RAO, M.D., J.D., FORMER U.S. FOOD AND DRUG ADMINISTRATION DIRECTOR OF THE OFFICE OF ORPHAN PRODUCTS DEVELOPMENT, AS VICE PRESIDENT, REGULATORY POLICY AND PATIENT ADVOCACY Source text for Eikon: Further company coverage:
* ROCKET PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
CAPE CANAVERAL, Fla. An 11th-hour technical glitch prompted SpaceX to postpone its planned launch on Monday of a new NASA space telescope designed to detect worlds beyond our solar system, delaying for at least 48 hours a quest to expand astronomers' known inventory of so-called exoplanets.
* ROCKET PHARMACEUTICALS REPORTS FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS
* ROCKET PHARMACEUTICALS PRICES PUBLIC OFFERING OF COMMON STOCK
* ROCKET PHARMACEUTICALS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
- Institutional Top Ideas: Cormorant Asset Management
- Rocket Pharmaceuticals (RCKT) Presents At 2018 UBS Global Healthcare Conference - Slideshow
- Rocket Pharmaceuticals (RCKT) Presents At 21st Annual Meeting of the American Society of Gene and Cell Therapy - Slideshow
- Your Daily Pharma Scoop: Abeona Presents Strong Data, Glaxo Nucala Treatment Benefit, Rocket Pharma's Gene Therapy Data
- Institutional Top Ideas Series: Opaleye Management
- Reader Inquiry: Is There Further Upside Ahead For Rocket Pharmaceuticals?